20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
Ref.: C.L.4.2021
The World Health Organization (WHO) presents its compliments to the Member States
and has the honour to inform them that WHO, with the support of the Ministry of Health of
Argentina, is organizing the Third Fair Pricing Forum. Due to the coronavirus disease
(COVID-19) Public Health Emergency of International Concern, the Forum will take place
virtually from 13 to 22 April 2021.
The meeting is the third forum that focuses on improving access to medicines and health
products through fair pricing, following the inaugural forum held in the Netherlands in 2017
(10–11 May) and the second forum in South Africa in 2019 (11–13 April). In 2019, the World
Health Assembly adopted Resolution WHA72.8 on Improving the transparency of markets for
medicines, vaccines, and other health products. The resolution requests the Director-General,
inter alia, “To continue its efforts to biennially convene the Fair Pricing Forum with Member
States and all relevant stakeholders to discuss the affordability and transparency of prices and
costs relating to health products”.
In line with this resolution, the Forum will bring together representatives from Member
States and relevant stakeholders to achieve the following three objectives:
1. To share countries’ experiences, including from the COVID-19 pandemic, in
ensuring affordability and transparency of prices and costs of health products.
2. To advance discussion and knowledge on approaches and system factors pertaining
to the pricing and R&D of pharmaceutical products for enhancing affordability,
transparency and innovation, and achieving health sustainable development goals.
3. To activate support for countries to achieve more affordable and fairer access to
pharmaceutical products during the COVID-19 pandemic and beyond.
WHO has the pleasure to request your Government to nominate up to three senior
policy-makers to participate in the Fair Pricing Forum. Potential participants would meet the
relevant characteristics described below, as applicable to country context:
• policy- and decision-makers responsible for national medicines and health products
pricing policies and/or price regulations;
• policy- and decision-makers responsible for national policies and programmes,
including financing of health products costs, to ensure equitable and universal access to
essential medicines and health products;
Page 2
C.L.4.2021
• key national payers, such as health insurance or medicines procurement agencies that
negotiate or manage pricing strategies, when purchasing essential medicines and other
essential health products.
Details of nominees to join the 3rd Fair Pricing Forum should be sent to
[email protected] no later than 29 March 2021, indicating:
Name:
Title:
Gender:
Affiliation:
Position:
City:
Country:
E-mail:
Phone number (optional):
The World Health Organization takes this opportunity to renew to Member States the
assurance of its highest consideration.
GENEVA, 1 March 2021
Saatja: <
[email protected]>
Saadetud: 02.03.2021 12:57
Koopia: <
[email protected]>
Teema: WHO: C.L.4.2021 (Third Fair Pricing Forum)
Dear Member States of the World Health Organization,Please find attached,
in the six official languages, C.L.4.2021 regarding the Third Fair
Pricing Forum that will take place virtually from 13 to 22 April
2021.Should you have questions regarding C.L.4.2021, please send an email
to .Best regards,Department of Governing BodiesWorld Health Organization